| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_718a40268150a2c24e6f99a6375a8643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49d2e25ad9a22c3b29107e2ee2e3356a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0a6c0a4bad8d6eba6bfe967a3fb808 |
| publicationDate |
2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020083871-A |
| titleOfInvention |
Nonobstructive hypertrophic cardiomyopathy drug |
| abstract |
PROBLEM TO BE SOLVED: To provide a medicine for non-obstructive hypertrophic cardiomyopathy. The non-obstructive hypertrophic cardiomyopathy of the present invention comprises a compound represented by the following formula (1) or a salt thereof. [Chemical 1] [Selection diagram] |
| priorityDate |
2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |